Other OTC Pharmaceuticals - Belarus

  • Belarus
  • In Belarus, the revenue generated in the Other OTC Pharmaceuticals market amounts to US$280.90m in 2024.
  • This market is expected to grow annually by 0.78% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$7,171.00m in 2024.
  • In terms of per person revenues, in Belarus, each individual generates US$29.71 in 2024.
  • Belarus has seen a rise in the demand for other OTC pharmaceuticals, driven by the increasing awareness of self-medication and the availability of a wide range of products in the market.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Belarus is experiencing steady growth due to changing customer preferences and trends in the market. Customer preferences in the Other OTC Pharmaceuticals market in Belarus are shifting towards self-medication and a preference for over-the-counter products. This is driven by the convenience and accessibility of these products, as well as a growing awareness of the benefits of self-care. Customers are increasingly seeking out OTC products for common ailments and minor health issues, such as headaches, colds, and allergies. This shift in customer preferences is not unique to Belarus, but is a global trend seen in many countries.Trends in the market are also contributing to the growth of the Other OTC Pharmaceuticals market in Belarus. One major trend is the increasing availability of OTC products in pharmacies and retail stores. Pharmacies are expanding their OTC product offerings to meet the demand of customers, and retail stores are dedicating more shelf space to OTC products. This trend is driven by the growing number of partnerships between pharmaceutical companies and retailers, as well as the increasing number of OTC products being launched in the market.Another trend in the market is the growing popularity of natural and herbal remedies. Customers are becoming more interested in alternative medicine and are seeking out OTC products that are derived from natural sources. This trend is influenced by a desire for more holistic and sustainable healthcare options. Pharmaceutical companies are responding to this trend by launching OTC products that are marketed as natural or herbal remedies.Local special circumstances in Belarus are also contributing to the growth of the Other OTC Pharmaceuticals market. One special circumstance is the relatively high out-of-pocket healthcare expenses in the country. This means that customers are more likely to turn to OTC products as a cost-effective alternative to prescription medications. Additionally, the aging population in Belarus is driving the demand for OTC products, as older individuals are more likely to experience common health issues that can be treated with OTC medications.Underlying macroeconomic factors, such as increasing disposable income and improvements in healthcare infrastructure, are also fueling the growth of the Other OTC Pharmaceuticals market in Belarus. As disposable income increases, customers have more money to spend on healthcare products, including OTC medications. Improvements in healthcare infrastructure, such as the expansion of pharmacies and the availability of healthcare services, are making it easier for customers to access and purchase OTC products.Overall, the Other OTC Pharmaceuticals market in Belarus is experiencing growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As customers continue to seek out convenient and accessible healthcare options, the demand for OTC products is expected to continue to rise in Belarus.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)